Neurogastroenterology and Motility

Actions of sumatriptan on myenteric neurones: relief from an old headache in the enteric nervous system?
pp. 1-3(3)
Author: galligan, j. j.

Chronic constipation: advances in management
pp. 4-10(7)
Author: wald, a.

A new method for evaluation of intestinal muscle contraction properties: studies in normal subjects and in patients with systemic sclerosis
pp. 11-19(9)
Authors: gregersen, h.; liao, d.; pedersen, j.; drewes, a. m.

Nutrient-dependent enhancement of rectal sensitivity in irritable bowel syndrome (IBS)
pp. 20-29(10)
Authors: simrén, m.; agerforz, p.; björnsson, e. s.; abrahamsson, h.

Pharmacodynamic effects of a novel prokinetic 5-HT₄ receptor agonist, ATI-7505, in humans
pp. 30-38(9)
Authors: camilleri, m.; vazquez-roque, m. i.; burton, d.; ford, t.; mckinzie, s.; zinsmeister, a. r.; druzgala, p.

Sumatriptan is an agonist at 5-HT_1P receptors on myenteric neurones in the guinea-pig gastric antrum
pp. 39-46(8)
Authors: tack, j.; berghe, p. vanden; coulie, b.; janssens, j.

Muscarinic acetylcholine receptor activation increases transcellular transport of macromolecules across mouse and human intestinal epithelium in vitro
pp. 47-56(10)
Authors: cameron, h. l.; perdue, m. h.

Colonic luminal proteases activate colonocyte proteinase-activated receptor-2 and regulate paracellular permeability in mice
pp. 57-65(9)
Authors: róka, r.; demaude, j.; cenac, n.; ferrier, l.; salvador-cartier, c.; garcia-villar, r.; fioramonti, j.; bueno, l.

The relationship between the effects of short-chain fatty acids on intestinal motility in vitro and GPR43 receptor activation
pp. 66-74(9)
Authors: dass, n. b.; john, a. k.; bassil, a. k.; crumbley, c. w.; shehee, w. r.; maurio, f. p.; moore, g. b. t.; taylor, c. m.; sanger, g. j.

Chronic abdominal wall pain (CAWP)
pp. 75-75(1)
Author: Greenbaum, David S.